Extract from the Register of European Patents

EP About this file: EP4545075

EP4545075 - CALPAIN INHIBITOR [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  28.03.2025
Database last updated on 21.03.2026
FormerThe international publication has been made
Status updated on  29.12.2023
Most recent event   Tooltip23.01.2026New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Goryo Chemical, Inc.
Earee Bldg. 5F
Kita 8 Nishi 18-35-100
Chuo-ku
Sapporo-shi, Hokkaido 060-0008 / JP
[2025/18]
Inventor(s)01 / SUZUKI, Yuki
Sapporo-shi, Hokkaido 060-0008 / JP
02 / SANO, Yusuke
Sapporo-shi, Hokkaido 060-0008 / JP
 [2025/18]
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[2025/18]
Application number, filing date23827190.220.06.2023
[2025/18]
WO2023JP22740
Priority number, dateJP2022010143223.06.2022         Original published format: JP 2022101432
[2025/18]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2023249007
Date:28.12.2023
Language:JA
[2023/52]
Type: A1 Application with search report 
No.:EP4545075
Date:30.04.2025
Language:EN
[2025/18]
Search report(s)International search report - published on:JP28.12.2023
ClassificationIPC:A61K31/16
[2025/18]
CPC:
A61P3/10 (EP); C07C237/06 (US); A61K31/195 (US);
A61K31/341 (US); A61P11/00 (EP); A61P21/00 (EP);
A61P25/00 (EP); A61P27/02 (EP); A61P27/06 (EP);
A61P27/12 (EP); A61P29/00 (EP); A61P31/00 (EP);
A61P35/00 (EP); A61P37/06 (EP); A61P43/00 (EP);
A61P9/00 (EP); C07C237/22 (EP); C07D261/18 (EP);
C07D263/34 (EP); C07D305/08 (EP); C07D307/24 (EP,US);
C07D307/68 (EP); C07D493/10 (US); C07C2601/02 (EP);
C07C2601/04 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   ME,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2025/18]
TitleGerman:CALPAIN-HEMMER[2025/18]
English:CALPAIN INHIBITOR[2025/18]
French:INHIBITEUR DE CALPAÏNE[2025/18]
Entry into regional phase27.12.2024Translation filed 
09.01.2025National basic fee paid 
09.01.2025Search fee paid 
09.01.2025Designation fee(s) paid 
09.01.2025Examination fee paid 
Examination procedure27.12.2024Amendment by applicant (claims and/or description)
09.01.2025Examination requested  [2025/18]
21.01.2026Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time
Fees paidPenalty fee
Additional fee for renewal fee
30.06.202503   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X] US5514694  (POWERS JAMES C et al.) [X] 1, 4-7, 11-16 * claims, claim 14, etc., table 3, etc. *
 [X] US2011166141  (LIN CHUN-CHENG et al.) [X] 1, 4-6, 12-16 * claims, examples, tables 1, 2 *
 [X] JP2021534133  (上海 インスティテュート オブ マテリア メディカ、チャイニーズ アカデミー オブ サイエンシーズSHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES et al.) [X] 1-2, 4-6, 12-16 * claims, examples, etc. *
 [A] WO2012021788  (BANYAN BIOMARKERS et al.) [A] 1-16 * claims, examples *
 [A] WO2012021800  (BANYAN BIOMARKERS et al.) [A] 1-16 * claims, examples *
 [A] WO2004009537  (SENJU PHARMA CO et al.) [A] 1-16 * claims, examples, etc. *
 [XP] WO2022129953  (HEPTARES THERAPEUTICS LTD et al.) [XP] 1, 4-6, 12-16 * claims, examples, etc. *
 [X]   LI ZHAOZHAO,ET AL: "Novel Peptidyl .alpha.-Keto Amide Inhibitors of Calpains and Other Cysteine Proteases", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 39, no. 20, 1 January 1996 (1996-01-01), US , pages 4089 - 4098, XP002323651, ISSN: 0022-2623, DOI: 10.1021/jm950541c [X] 1, 4-7, 11-16 * page 4089, fig. 1, table 2 *

DOI:   http://dx.doi.org/10.1021/jm950541c
by applicantJP2002047256
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.